Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AARD
AARD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AARD News
Aardvark Therapeutics Faces Securities Fraud Investigation
May 21 2026
PRnewswire
Aardvark Therapeutics Halts HERO Trial, Shares Plummet
May 19 2026
PRnewswire
Aardvark Therapeutics Faces FDA Clinical Hold on ARD-101
May 15 2026
seekingalpha
Aardvark Therapeutics Downgraded to Neutral Amid Uncertainties
May 15 2026
stocktwits
Healthcare Stocks Decline on Friday Afternoon
May 15 2026
Yahoo Finance
FDA Imposes Full Clinical Hold on Aardvark's ARD-101 Studies
May 15 2026
Newsfilter
Aardvark Therapeutics Faces Full Clinical Hold on ARD-101
May 14 2026
stocktwits
Aardvark Therapeutics Faces FDA Clinical Hold on ARD-101
May 14 2026
Newsfilter
Aardvark Therapeutics Halts Phase 3 Trial, Shares Plunge
May 14 2026
Globenewswire
Aardvark Therapeutics Halts HERO Trial Amid Safety Concerns
May 07 2026
PRnewswire
Aardvark Therapeutics Q1 Financial Results Overview
May 07 2026
seekingalpha
Aardvark Therapeutics Shares Plummet After Trial Halt
Apr 22 2026
PRnewswire
Aardvark Therapeutics Shares Plunge After Trial Halt
Apr 10 2026
PRnewswire
Aardvark Therapeutics Halts HERO Trial, Shares Plunge 56%
Apr 09 2026
Globenewswire
Aardvark Therapeutics Under Investigation for Securities Fraud
Mar 24 2026
Globenewswire
AARDVARK THERAPEUTICS INC: B. RILEY LOWERS TARGET PRICE FROM $32 TO $8
Mar 24 2026
moomoo
Show More News
